TMDX Q2 2019 Earnings — TransMedics Group, Inc. Revenue & Financial Results | Market Cap Arena

TMDXTransMedics Group, Inc.

$4B

Q2 2019 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$6M+94.4% YoY

Gross Profit

$3M58.8% margin

Operating Income

-$8M-136.0% margin

Net Income

-$9M-162.3% margin

EPS (Diluted)

$-0.70

QoQ Revenue Growth

+21.2%

Cash Flow

Operating Cash Flow

-$12M

Free Cash Flow

-$12M

Stock-Based Comp.

$220,000

Balance Sheet

Total Assets

$121M

Total Liabilities

$50M

Stockholders' Equity

$71M

Cash & Equivalents

$47M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$6M	$3M	+94.4%
Gross Profit	$3M	$1M	+182.7%
Operating Income	-$8M	-$5M	-49.4%
Net Income	-$9M	-$6M	-50.4%

Revenue Segments

Ocs Heart Product

$3M47%

Ocs Lung Product

$2M39%

Ocs Liver Product

$804,00014%

Geographic Segments

UNITED STATES

$4M82%

GERMANY

$358,0007%

ITALY

$287,0005%

AUSTRALIA

$175,0003%

Other Countries

$139,0003%